I will ask my question again and direct it to the “Curb your enthusiasts” on this board. Has there been any other COVID-19 S/C therapeutic candidates that have been granted open-label extension and/or EIND green light? It doesn’t make sense that the phlegmatic FDA just granted it to CYTODYN just for the asking.